Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Medical News Article on Follicular Lymphoma
New follicular lymphoma study findings have been reported from Sanofi Pasteur
2009 JUN 29 -- According to recent research from Toronto, Canada, "We enrolled 23 patients with relapsed follicular lymphoma (FL) in a prospective single-arm study of auto-SCT combined with in vivorituximab graft purging and post transplant rituximab maintenance. Minimal residual disease was monitored with quantitative PCR testing."
"With a median follow-up of 74.2 months, neither median overall survival (OS) nor PFS has been reached. Here, 5-year OS and 5-year PFS are 78% (95% confidence interval (CI) 61-95%) and 59% ( 95% CI 38-80%), respectively. Time to progression (TTP) with the experimental regimen was significantly improved compared with TTP...
In order to view the entire article, please read your options to the right
